50 related articles for article (PubMed ID: 23343186)
1. [(3)H]metyrapol and 4-[(131)i]iodometomidate label overlapping, but not identical, binding sites on rat adrenal membranes.
Berger ML; Hammerschmidt F; Qian R; Hahner S; Schirbel A; Stichelberger M; Schibli R; Yu J; Arion VB; Woschek A; Öhler E; Zolle IM
Mol Pharm; 2013 Mar; 10(3):1119-30. PubMed ID: 23343186
[TBL] [Abstract][Full Text] [Related]
2. New selective inhibitors of steroid 11beta-hydroxylation in the adrenal cortex. Synthesis and structure-activity relationship of potent etomidate analogues.
Zolle IM; Berger ML; Hammerschmidt F; Hahner S; Schirbel A; Peric-Simov B
J Med Chem; 2008 Apr; 51(7):2244-53. PubMed ID: 18348518
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective reductive metabolism of metyrapone and inhibitory activity of metyrapone metabolites, metyrapol enantiomers, on steroid 11 beta-hydroxylase in the rat.
Nagamine S; Horisaka E; Fukuyama Y; Maetani K; Matsuzawa R; Iwakawa S; Asada S
Biol Pharm Bull; 1997 Feb; 20(2):188-92. PubMed ID: 9057984
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship of etomidate derivatives at the GABA(A) receptor: Comparison with binding to 11beta-hydroxylase.
Atucha E; Hammerschmidt F; Zolle I; Sieghart W; Berger ML
Bioorg Med Chem Lett; 2009 Aug; 19(15):4284-7. PubMed ID: 19497738
[TBL] [Abstract][Full Text] [Related]
5. Steroid 11beta-hydroxylation in beef adrenal cortex mitochondria. Binding affinity and capacity of specific (14C)steroids and for (3H)metyrapol, an inhibitor of the 11beta-hydroxylation reaction.
Satre M; Vignais PV
Biochemistry; 1974 May; 13(10):2201-9. PubMed ID: 4826891
[No Abstract] [Full Text] [Related]
6. ( 3 H)metyrapol as a tool for studies of interactions of deoxycorticosterone with adrenal cortex mitochondria.
Satre M; Lunardi J; Vignais PV
FEBS Lett; 1972 Oct; 26(1):193-6. PubMed ID: 4636729
[No Abstract] [Full Text] [Related]
7. 2-(3-Methyl-3H-diaziren-3-yl)ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate: a derivative of the stereoselective general anesthetic etomidate for photolabeling ligand-gated ion channels.
Husain SS; Ziebell MR; Ruesch D; Hong F; Arevalo E; Kosterlitz JA; Olsen RW; Forman SA; Cohen JB; Miller KW
J Med Chem; 2003 Mar; 46(7):1257-65. PubMed ID: 12646036
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo primate evaluation of carbon-11-etomidate and carbon-11-metomidate as potential tracers for PET imaging of the adrenal cortex and its tumors.
Bergström M; Bonasera TA; Lu L; Bergström E; Backlin C; Juhlin C; Långström B
J Nucl Med; 1998 Jun; 39(6):982-9. PubMed ID: 9627330
[TBL] [Abstract][Full Text] [Related]
9. Sedative-hypnotic Binding to 11β-hydroxylase.
Pejo E; Zhou X; Husain SS; Raines DE
Anesthesiology; 2016 Nov; 125(5):943-951. PubMed ID: 27541316
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of metyrapone. III. Formation of an alpha-pyridone metabolite by rat hepatic soluble enzymes.
Damani LA; Crooks PA; Cowan DA
Drug Metab Dispos; 1981; 9(3):270-3. PubMed ID: 6113939
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamic and pharmacokinetic characterization of the aldosterone synthase inhibitor FAD286 in two rodent models of hyperaldosteronism: comparison with the 11beta-hydroxylase inhibitor metyrapone.
Rigel DF; Fu F; Beil M; Hu CW; Liang G; Jeng AY
J Pharmacol Exp Ther; 2010 Jul; 334(1):232-43. PubMed ID: 20354176
[TBL] [Abstract][Full Text] [Related]
12. Carboetomidate: an analog of etomidate that interacts weakly with 11β-hydroxylase.
Shanmugasundararaj S; Zhou X; Neunzig J; Bernhardt R; Cotten JF; Ge R; Miller KW; Raines DE
Anesth Analg; 2013 Jun; 116(6):1249-56. PubMed ID: 23492967
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of metyrapone. 2-Chromatographic and mass spectral properties of the N-oxides of metyrapone and metyrapol.
Damani LA; Crooks PA; Cowan DA
Biomed Mass Spectrom; 1981 Jun; 8(6):270-7. PubMed ID: 7260343
[TBL] [Abstract][Full Text] [Related]
14. Alteration of the inhibitory effect of metyrapone by reduction to metyrapol during the metabolism of methacetin in vivo in mice.
Maser E; Legrum W
Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):283-9. PubMed ID: 3937061
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of the imidazole derivatives etomidate, ketoconazole and miconazole and of metyrapone on the secretion of cortisol and its precursors by human adrenocortical cells.
Lamberts SW; Bons EG; Bruining HA; de Jong FH
J Pharmacol Exp Ther; 1987 Jan; 240(1):259-64. PubMed ID: 3027305
[TBL] [Abstract][Full Text] [Related]
16. New inhibitors of steroid 11beta-hydroxylase. Structure--activity relationship studies of metyrapone-like compounds.
Napoli JL; Counsell RE
J Med Chem; 1977 Jun; 20(6):762-6. PubMed ID: 874952
[TBL] [Abstract][Full Text] [Related]
17. Dimethoxy-etomidate: A Nonhypnotic Etomidate Analog that Potently Inhibits Steroidogenesis.
McGrath M; Ma C; Raines DE
J Pharmacol Exp Ther; 2018 Feb; 364(2):229-237. PubMed ID: 29203576
[TBL] [Abstract][Full Text] [Related]
18. The urinary metabolic profile of metyrapone in the rat. Identification of two novel isomeric metyrapol N-oxide metabolites.
Usansky JI; Damani LA
Drug Metab Dispos; 1992; 20(1):64-9. PubMed ID: 1346999
[TBL] [Abstract][Full Text] [Related]
19. Assay of metyrapone, metyrapol and the isomeric mono-N-oxides of metyrapone in biological fluids by high-performance liquid chromatography.
Usansky JI; Damani LA
J Chromatogr; 1991 Feb; 563(2):283-98. PubMed ID: 2055992
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of a novel nonpeptide antagonist radioligand, (+/-)-N-[2-methyl-4-methoxyphenyl]-1-(1-(methoxymethyl) propyl)-6-methyl-1H-1,2,3-triazolo[4,5-c]pyridin-4-amine ([3H]SN003) for corticotropin-releasing factor1 receptors.
Zhang G; Huang N; Li YW; Qi X; Marshall AP; Yan XX; Hill G; Rominger C; Prakash SR; Bakthavatchalam R; Rominger DH; Gilligan PJ; Zaczek R
J Pharmacol Exp Ther; 2003 Apr; 305(1):57-69. PubMed ID: 12649353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
